Steris (STE) Long-Term Debt Repayments (2021)
Steris (STE) recorded quarterly Long-Term Debt Repayments of $1.1 billion in Q3 2021, up 251.49% quarter-over-quarter from -$721.3 million in Q2 2021.
Steris (STE) Long-Term Debt Repayments (2021) Analysis & Trends
Steris' Long-Term Debt Repayments history runs 1 years deep, the most recent figure standing at $1.1 billion for Q3 2021.
- In Q3 2021, Long-Term Debt Repayments changed N/A year-over-year to $1.1 billion; the TTM figure through Jun 2022 stood at $1.1 billion (up 259.21% YoY), while the FY2022 annual figure was $371.4 million, up 961.03% from the prior year.
- Long-Term Debt Repayments was $1.1 billion for Q3 2021 at Steris, up from -$721.3 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $1.1 billion in Q3 2021 to a low of -$721.3 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 1.09 Bn |
| Sep 30, 2021 | 1.09 Bn |
| Jun 30, 2021 | -721.28 Mn |
| Jun 30, 2021 | -721.28 Mn |
| Mar 31, 2021 | 35.00 Mn |
| Mar 31, 2021 | 35.00 Mn |